News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
716,546 Results
Type
Article (42621)
Company Profile (437)
Press Release (673488)
Multimedia
Podcasts (80)
Webinars (13)
Section
Business (208922)
Career Advice (2039)
Deals (36031)
Drug Delivery (104)
Drug Development (83614)
Employer Resources (173)
FDA (16453)
Job Trends (15122)
News (353097)
Policy (33132)
Tag
Academia (2649)
Accelerated approval (6)
Adcomms (24)
Allergies (88)
Alliances (51008)
ALS (99)
Alzheimer's disease (1436)
Antibody-drug conjugate (ADC) (147)
Approvals (16434)
Artificial intelligence (278)
Autoimmune disease (26)
Automation (16)
Bankruptcy (372)
Best Places to Work (11850)
BIOSECURE Act (19)
Biosimilars (107)
Biotechnology (331)
Bladder cancer (83)
Brain cancer (27)
Breast cancer (299)
Cancer (2374)
Cardiovascular disease (191)
Career advice (1706)
Career pathing (30)
CAR-T (161)
Cell therapy (456)
Cervical cancer (20)
Clinical research (67888)
Collaboration (899)
Company closure (2)
Compensation (566)
Complete response letters (24)
COVID-19 (2655)
CRISPR (47)
C-suite (262)
Cystic fibrosis (106)
Data (2335)
Decentralized trials (2)
Denatured (29)
Depression (52)
Diabetes (280)
Diagnostics (6440)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (127)
Drug pricing (111)
Drug shortages (26)
Duchenne muscular dystrophy (103)
Earnings (88287)
Editorial (43)
Employer branding (21)
Employer resources (147)
Events (116364)
Executive appointments (759)
FDA (17837)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (802)
Gene editing (119)
Generative AI (20)
Gene therapy (337)
GLP-1 (756)
Government (4522)
Grass and pollen (4)
Guidances (150)
Healthcare (19177)
Huntington's disease (25)
IgA nephropathy (30)
Immunology and inflammation (136)
Indications (30)
Infectious disease (2802)
Inflammatory bowel disease (150)
Inflation Reduction Act (11)
Influenza (53)
Intellectual property (99)
Interviews (312)
IPO (16810)
IRA (43)
Job creations (3711)
Job search strategy (1450)
Kidney cancer (10)
Labor market (43)
Layoffs (506)
Leadership (18)
Legal (8003)
Liver cancer (77)
Lung cancer (332)
Lymphoma (158)
Machine learning (9)
Management (58)
Manufacturing (332)
MASH (76)
Medical device (13539)
Medtech (13544)
Mergers & acquisitions (19785)
Metabolic disorders (738)
Multiple sclerosis (84)
NASH (19)
Neurodegenerative disease (105)
Neuropsychiatric disorders (33)
Neuroscience (2022)
NextGen: Class of 2025 (6765)
Non-profit (4558)
Now hiring (40)
Obesity (394)
Opinion (224)
Ovarian cancer (82)
Pain (96)
Pancreatic cancer (89)
Parkinson's disease (157)
Partnered (21)
Patents (244)
Patient recruitment (116)
Peanut (47)
People (58767)
Pharmaceutical (86)
Pharmacy benefit managers (20)
Phase I (21327)
Phase II (29960)
Phase III (22150)
Pipeline (1369)
Policy (155)
Postmarket research (2602)
Preclinical (9157)
Press Release (67)
Prostate cancer (111)
Psychedelics (37)
Radiopharmaceuticals (263)
Rare diseases (409)
Real estate (6022)
Recruiting (66)
Regulatory (22811)
Reports (47)
Research institute (2419)
Resumes & cover letters (352)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (78)
Series A (141)
Series B (93)
Service/supplier (11)
Sickle cell disease (58)
Special edition (19)
Spinal muscular atrophy (152)
Sponsored (30)
Startups (3771)
State (2)
Stomach cancer (14)
Supply chain (69)
Tariffs (48)
The Weekly (49)
Vaccines (719)
Venture capitalists (44)
Weight loss (257)
Women's health (38)
Worklife (17)
Date
Last 7 days (950)
Last 30 days (3062)
Last 365 days (33357)
2025 (11993)
2024 (36309)
2023 (41029)
2022 (52292)
2021 (56801)
2020 (54965)
2019 (47480)
2018 (35748)
2017 (33076)
2016 (32428)
2015 (38472)
2014 (32241)
2013 (27148)
2012 (29255)
2011 (29906)
2010 (28018)
Location
Africa (745)
Alabama (59)
Alaska (7)
Arizona (241)
Arkansas (14)
Asia (39370)
Australia (6551)
California (6513)
Canada (2073)
China (547)
Colorado (278)
Connecticut (292)
Delaware (159)
Europe (86098)
Florida (950)
Georgia (213)
Idaho (57)
Illinois (566)
India (25)
Indiana (322)
Iowa (12)
Japan (173)
Kansas (109)
Kentucky (25)
Louisiana (12)
Maine (62)
Maryland (940)
Massachusetts (4923)
Michigan (225)
Minnesota (408)
Mississippi (2)
Missouri (82)
Montana (29)
Nebraska (25)
Nevada (67)
New Hampshire (67)
New Jersey (1821)
New Mexico (30)
New York (1820)
North Carolina (1054)
North Dakota (8)
Northern California (2839)
Ohio (211)
Oklahoma (14)
Oregon (38)
Pennsylvania (1435)
Puerto Rico (13)
Rhode Island (34)
South America (1121)
South Carolina (25)
South Dakota (1)
Southern California (2440)
Tennessee (105)
Texas (964)
United States (24492)
Utah (191)
Virginia (157)
Washington D.C. (66)
Washington State (585)
West Virginia (3)
Wisconsin (57)
716,546 Results for "century therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Century Therapeutics Announces Two Upcoming Presentations at the ASGCT 28th Annual Meeting
April 28, 2025
·
5 min read
Press Releases
Century Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update
March 20, 2025
·
13 min read
Press Releases
Century Therapeutics to Host Live Fireside Chat Focused on Newly Prioritized Preclinical Cell Therapy Programs for Autoimmune Diseases and Cancer on Tuesday, April 22, 2025
April 15, 2025
·
5 min read
Business
Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updates
Century Therapeutics, Inc. today reported financial results and business highlights for the full year ended December 31, 2023.
March 14, 2024
·
14 min read
Business
Century Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
Century Therapeutics, Inc. (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology and autoimmune diseases, today reported financial results and business highlights for the first quarter ended March 31, 2024.
May 9, 2024
·
13 min read
Press Releases
Century Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference
November 26, 2024
·
1 min read
Press Releases
Century Therapeutics to Present at Guggenheim’s Inaugural Healthcare Innovation Conference
November 5, 2024
·
1 min read
Press Releases
Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates
November 6, 2024
·
17 min read
Pharm Country
Century Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
Century Therapeutics today announced that members of the management team will participate in a virtual fireside chat and panel at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit.
April 23, 2024
·
1 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
1 of 71,655
Next
